Daniel Grosslight
Stock Analyst at Citigroup
(1.10)
# 3,676
Out of 4,944 analysts
102
Total ratings
32.2%
Success rate
-13.67%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OMI Owens & Minor | Maintains: Buy | $11 → $7 | $5.47 | +27.97% | 7 | Aug 12, 2025 | |
| HCAT Health Catalyst | Downgrades: Neutral | $6.5 → $3.5 | $3.00 | +16.67% | 10 | Aug 8, 2025 | |
| AGL agilon health | Downgrades: Neutral | $3 → $1 | $0.89 | +12.17% | 6 | Aug 6, 2025 | |
| WAY Waystar Holding | Initiates: Buy | $45 | $34.58 | +30.13% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $146.30 | +16.20% | 9 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $47.96 | -37.45% | 11 | May 6, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $6.87 | +27.37% | 11 | Apr 25, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $8.80 | +104.55% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $3.50 | +78.57% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $659.01 | +2.73% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $27.85 | +25.67% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $20.71 | +20.71% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $3.46 | +189.02% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $9.83 | -18.62% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.02 | -38.12% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.50 | +40.00% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.54 | +36.27% | 1 | Dec 11, 2019 |
Owens & Minor
Aug 12, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $5.47
Upside: +27.97%
Health Catalyst
Aug 8, 2025
Downgrades: Neutral
Price Target: $6.5 → $3.5
Current: $3.00
Upside: +16.67%
agilon health
Aug 6, 2025
Downgrades: Neutral
Price Target: $3 → $1
Current: $0.89
Upside: +12.17%
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $34.58
Upside: +30.13%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $146.30
Upside: +16.20%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $47.96
Upside: -37.45%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $6.87
Upside: +27.37%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $8.80
Upside: +104.55%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $3.50
Upside: +78.57%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $659.01
Upside: +2.73%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $27.85
Upside: +25.67%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $20.71
Upside: +20.71%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $3.46
Upside: +189.02%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $9.83
Upside: -18.62%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.02
Upside: -38.12%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.50
Upside: +40.00%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.54
Upside: +36.27%